{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:34:51Z","timestamp":1780626891286,"version":"3.54.1"},"reference-count":100,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3836,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1002\/lt.20379","type":"journal-article","created":{"date-parts":[[2005,2,18]],"date-time":"2005-02-18T00:25:48Z","timestamp":1108686348000},"page":"249-260","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Management of pre\u2013liver transplantation patient\u2014Part 2"],"prefix":"10.1097","volume":"11","author":[{"given":"Pratima","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rakela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20250326","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0025-6196(11)63772-5","article-title":"Pathophysiology and treatment of variceal hemorrhage.","volume":"71","author":"Roberts","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"R2-2-20250326","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/gut.49.5.682","article-title":"Improving prognosis following a first variceal haemorrhage over four decades.","volume":"49","author":"McCormick","year":"2001","journal-title":"Gut"},{"key":"R3-2-20250326","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0016-5107(81)73224-3","article-title":"Prediction of variceal hemorrhage by esophageal endoscopy.","volume":"27","author":"Beppu","year":"1981","journal-title":"Gastrointest Endosc"},{"key":"R4-2-20250326","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0950-3528(97)90038-5","article-title":"Natural history. Clinicalhaemodynamic correlations. Prediction of the risk of bleeding.","volume":"11","author":"DAmico","year":"1997","journal-title":"Baillieres Clin Gastroenterol"},{"key":"R5-2-20250326","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/0016-5085(88)90372-1","article-title":"Optimization of ascitic fluid culture technique.","volume":"95","author":"Runyon","year":"1988","journal-title":"Gastroenterology"},{"key":"R6-2-20250326","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/BF01307509","article-title":"Shortterm oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a doubleblind crossover trial.","volume":"36","author":"Riggio","year":"1991","journal-title":"Dig Dis Sci"},{"key":"R7-2-20250326","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0039-6109(05)70004-9","article-title":"Management of portal hypertensionrelated bleeding.","volume":"79","author":"Vargas","year":"1999","journal-title":"Surg Clin North Am"},{"key":"R8-2-20250326","first-page":"1082","article-title":"Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.","volume":"18","author":"Feu","year":"1993","journal-title":"Hepatology"},{"key":"R9-2-20250326","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJM199105303242202","article-title":"Betaadrenergicantagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. FrancoItalian Multicenter Study Group.","volume":"324","author":"Poynard","year":"1991","journal-title":"N Engl J Med"},{"key":"R10-2-20250326","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep.1840060119","article-title":"Shortterm effects of propranolol on portal venous pressure.","volume":"6","author":"GarciaTsao","year":"1986","journal-title":"Hepatology"},{"key":"R11-2-20250326","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-114-10-869","article-title":"Propranolol compared with propranolol plus isosorbide5mononitrate for portal hypertension in cirrhosis. A randomized controlled study.","volume":"114","author":"GarciaPagan","year":"1991","journal-title":"Ann Intern Med"},{"key":"R12-2-20250326","first-page":"1938","article-title":"A metaanalysis of prophylactic endoscopic sclerotherapy for esophageal varices.","volume":"89","author":"Fardy","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"R13-2-20250326","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-2007-1009085","article-title":"Prophylactic sclerotherapy for esophageal varices in highrisk cirrhotic patients selected by endoscopic and hemodynamic criteria: a randomized, singlecenter controlled trial.","volume":"26","author":"Paquet","year":"1994","journal-title":"Endoscopy"},{"key":"R14-2-20250326","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0270-9139(95)90388-7","article-title":"The treatment of portal hypertension: a metaanalytic review.","volume":"22","author":"DAmico","year":"1995","journal-title":"Hepatology"},{"key":"R15-2-20250326","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199904013401302","article-title":"Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.","volume":"340","author":"Sarin","year":"1999","journal-title":"N Engl J Med"},{"key":"R16-2-20250326","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.20284","article-title":"Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.","volume":"40","author":"Schepke","year":"2004","journal-title":"Hepatology"},{"key":"R17-2-20250326","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/s-2007-1007132","article-title":"Transjugular intrahepatic portosystemic shunt.","volume":"19","author":"Burroughs","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R18-2-20250326","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/jlts.2003.50045","article-title":"Transjugular intrahepatic portosystemic shunts: an update.","volume":"9","author":"Rosado","year":"2003","journal-title":"Liver Transpl"},{"key":"R19-2-20250326","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","article-title":"Pharmacological treatment of portal hypertension: an evidencebased approach.","volume":"19","author":"DAmico","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R20-2-20250326","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.510290608","article-title":"Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a metaanalysis.","volume":"29","author":"Bernard","year":"1999","journal-title":"Hepatology"},{"key":"R21-2-20250326","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0168-8278(00)80320-7","article-title":"Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.","volume":"33","author":"de Franchis","year":"2000","journal-title":"J Hepatol"},{"key":"R22-2-20250326","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/003655298750027100","article-title":"Development of analogues: successes and failures.","volume":"226","author":"Bosch","year":"1998","journal-title":"Scand J Gastroenterol(Suppl)"},{"key":"R23-2-20250326","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM200101043440104","article-title":"Early administration of vapreotide for variceal bleeding in patients with cirrhosis. French Club for the Study of Portal Hypertension.","volume":"344","author":"Cales","year":"2001","journal-title":"N Engl J Med"},{"key":"R24-2-20250326","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM199508313330904","article-title":"Sclerotherapy with or without octreotide for acute variceal bleeding.","volume":"333","author":"Besson","year":"1995","journal-title":"N Engl J Med"},{"key":"R25-2-20250326","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-2007-1007131","article-title":"Endoscopic treatments for portal hypertension.","volume":"19","author":"de Franchis","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R26-2-20250326","first-page":"725A","article-title":"Distal splenorenal shunt versus transjugular intrahepatic portosystemic shunt: a prospective randomized controlled trial.","volume":"40","author":"Henderson","year":"2004","journal-title":"Hepatology"},{"key":"R27-2-20250326","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1001\/archinte.1986.00360230201029","article-title":"Paracentesis of ascitic fluid. A safe procedure.","volume":"146","author":"Runyon","year":"1986","journal-title":"Arch Intern Med"},{"key":"R28-2-20250326","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1128\/jcm.27.10.2145-2147.1989","article-title":"Improved method for bacteriological diagnosis of spontaneous bacterial peritonitis.","volume":"27","author":"Bobadilla","year":"1989","journal-title":"J Clin Microbiol"},{"key":"R29-2-20250326","first-page":"1605","article-title":"Comparison of two ascitic fluid culture methods in cirrhotic patients with spontaneous bacterial peritonitis.","volume":"85","author":"Castellote","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"R30-2-20250326","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.20066","article-title":"Management of adult patients with ascites due to cirrhosis.","volume":"39","author":"Runyon","year":"2004","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"R31-2-20250326","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004836-198100031-00016","article-title":"Diuresis in the ascitic patient: a randomized controlled trial of three regimens.","volume":"3","author":"Fogel","year":"1981","journal-title":"J Clin Gastroenterol"},{"key":"R32-2-20250326","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840400409","article-title":"Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.","volume":"40","author":"Heuman","year":"2004","journal-title":"Hepatology"},{"key":"R33-2-20250326","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1399-0012.1998.tb01102.x","article-title":"Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis.","volume":"12","author":"Abbasoglu","year":"1998","journal-title":"Clin Transplant"},{"key":"R34-2-20250326","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","article-title":"Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized doubleblind multicenter trial.","volume":"124","author":"Gerbes","year":"2003","journal-title":"Gastroenterology"},{"key":"R35-2-20250326","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0016-5085(83)90198-1","article-title":"Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the reninaldosterone system.","volume":"84","author":"PerezAyuso","year":"1983","journal-title":"Gastroenterology"},{"key":"R36-2-20250326","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"R37-2-20250326","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJM198912143212403","article-title":"Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites.","volume":"321","author":"Stanley","year":"1989","journal-title":"N Engl J Med"},{"key":"R38-2-20250326","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJM199109193251201","article-title":"Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.","volume":"325","author":"Gines","year":"1991","journal-title":"N Engl J Med"},{"key":"R39-2-20250326","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/BF02282343","article-title":"Peritoneal fibrosis in cirrhotics treated with peritoneovenous shunting for ascites. An autopsy study with clinical correlations.","volume":"41","author":"Stanley","year":"1996","journal-title":"Dig Dis Sci"},{"key":"R40-2-20250326","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJM199505043321803","article-title":"The transjugular intrahepatic portosystemic stentshunt procedure for refractory ascites.","volume":"332","author":"Ochs","year":"1995","journal-title":"N Engl J Med"},{"key":"R41-2-20250326","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","article-title":"The North American Study for the Treatment of Refractory Ascites.","volume":"124","author":"Sanyal","year":"2003","journal-title":"Gastroenterology"},{"key":"R42-2-20250326","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.","volume":"342","author":"Rossle","year":"2000","journal-title":"N Engl J Med"},{"key":"R43-2-20250326","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.","volume":"40","author":"Salerno","year":"2004","journal-title":"Hepatology"},{"key":"R44-2-20250326","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.","volume":"123","author":"Gines","year":"2002","journal-title":"Gastroenterology"},{"key":"R45-2-20250326","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","article-title":"Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.","volume":"25","author":"Lebrec","year":"1996","journal-title":"J Hepatol"},{"key":"R46-2-20250326","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","article-title":"Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.","volume":"32","author":"Rimola","year":"2000","journal-title":"J Hepatol"},{"key":"R47-2-20250326","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/hep.1840050319","article-title":"Cefotaxime is more effective than is ampicillintobramycin in cirrhotics with severe infections.","volume":"5","author":"Felisart","year":"1985","journal-title":"Hepatology"},{"key":"R48-2-20250326","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/0016-5085(91)90677-D","article-title":"Shortcourse versus longcourse antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients.","volume":"100","author":"Runyon","year":"1991","journal-title":"Gastroenterology"},{"key":"R49-2-20250326","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0016-5085(96)70069-0","article-title":"Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.","volume":"111","author":"Navasa","year":"1996","journal-title":"Gastroenterology"},{"key":"R50-2-20250326","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/gast.2001.22580","article-title":"Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis.","volume":"120","author":"GarciaTsao","year":"2001","journal-title":"Gastroenterology"},{"key":"R51-2-20250326","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1572-0241.2001.03964.x","article-title":"Hepatic encephalopathy.","volume":"96","author":"Blei","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R52-2-20250326","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-2007-1007237","article-title":"Astrocyticammonia interactions in hepatic encephalopathy.","volume":"16","author":"Norenberg","year":"1996","journal-title":"Semin Liver Dis"},{"key":"R53-2-20250326","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/hep.1840200136","article-title":"Hepatic encephalopathy in the age of TIPS.","volume":"20","author":"Blei","year":"1994","journal-title":"Hepatology"},{"key":"R54-2-20250326","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.510290309","article-title":"Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration.","volume":"29","author":"Clemmesen","year":"1999","journal-title":"Hepatology"},{"key":"R55-2-20250326","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.1840160326","article-title":"Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis.","volume":"16","author":"Riggio","year":"1992","journal-title":"Hepatology"},{"key":"R56-2-20250326","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.510230523","article-title":"Zinc supplementation and amino acidnitrogen metabolism in patients with advanced cirrhosis.","volume":"23","author":"Marchesini","year":"1996","journal-title":"Hepatology"},{"key":"R57-2-20250326","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0016-5085(91)90290-2","article-title":"Overt hepatic encephalopathy precipitated by zinc deficiency.","volume":"100","author":"Van der Rijt","year":"1991","journal-title":"Gastroenterology"},{"key":"R58-2-20250326","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/gut.15.12.999","article-title":"Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device.","volume":"15","author":"Brown","year":"1974","journal-title":"Gut"},{"key":"R59-2-20250326","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/jlts.2002.32983","article-title":"Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.","volume":"8","author":"Fontana","year":"2002","journal-title":"Liver Transpl"},{"key":"R60-2-20250326","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.510250609","article-title":"Therapeutic efficacy of LornithineLaspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebocontrolled, doubleblind study.","volume":"25","author":"Kircheis","year":"1997","journal-title":"Hepatology"},{"key":"R61-2-20250326","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.1840160123","article-title":"Sodium benzoate in the treatment of acute hepatic encephalopathy: a doubleblind randomized trial.","volume":"16","author":"Sushma","year":"1992","journal-title":"Hepatology"},{"key":"R62-2-20250326","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007245","article-title":"Newer approaches to therapy of hepatic encephalopathy.","volume":"16","author":"Ferenci","year":"1996","journal-title":"Semin Liver Dis"},{"key":"R63-2-20250326","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/gut.39.2.319","article-title":"Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study.","volume":"39","author":"Gyr","year":"1996","journal-title":"Gut"},{"key":"R64-2-20250326","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(02)01986-6","article-title":"Effects of dinucleoside polyphosphates on regulation of coronary vascular tone.","volume":"448","author":"van der Giet","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"R65-2-20250326","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.","volume":"94","author":"Gines","year":"1988","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"R66-2-20250326","first-page":"35","article-title":"Diagnostic approach to the cirrhotic patient with ascites.","volume":"25","author":"Arroyo","year":"1996","journal-title":"J Hepatol"},{"key":"R67-2-20250326","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/jhep.2003.50169","article-title":"Randomized trial comparing albumin and saline in the prevention of paracentesisinduced circulatory dysfunction in cirrhotic patients with ascites.","volume":"37","author":"SolaVera","year":"2003","journal-title":"Hepatology"},{"key":"R68-2-20250326","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"R69-2-20250326","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2007-1007201","article-title":"Hepatorenal syndrome.","volume":"17","author":"Bataller","year":"1997","journal-title":"Semin Liver Dis"},{"key":"R70-2-20250326","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1440-1746.2002.02778.x","article-title":"Hepatorenal syndrome in patients with cirrhosis.","volume":"17","author":"Moreau","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R71-2-20250326","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study.","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"R72-2-20250326","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"R73-2-20250326","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stentshunt in nontransplant cirrhotics with hepatorenal syndrome: a phase II study.","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"R74-2-20250326","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"R75-2-20250326","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/lt.500060326","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"key":"R76-2-20250326","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0168-8278(00)00108-2","article-title":"Hepatopulmonary syndrome in candidates for liver transplantation.","volume":"34","author":"Martinez","year":"2001","journal-title":"J Hepatol"},{"key":"R77-2-20250326","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-122-7-199504010-00008","article-title":"The hepatopulmonary syndrome.","volume":"122","author":"Lange","year":"1995","journal-title":"Ann Intern Med"},{"key":"R78-2-20250326","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hep.510250527","article-title":"Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation.","volume":"25","author":"Battaglia","year":"1997","journal-title":"Hepatology"},{"key":"R79-2-20250326","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0016-5085(95)90589-8","article-title":"Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome.","volume":"109","author":"Abrams","year":"1995","journal-title":"Gastroenterology"},{"key":"R80-2-20250326","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.46.1.1","article-title":"Hepatopulmonary syndromes.","volume":"46","author":"Krowka","year":"2000","journal-title":"Gut"},{"key":"R81-2-20250326","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1183\/09031936.98.11051153","article-title":"Pulmonary vascular disorders in portal hypertension.","volume":"11","author":"Herve","year":"1998","journal-title":"Eur Respir J"},{"key":"R82-2-20250326","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/gast.1997.v113.agast971130728","article-title":"Lack of efficacy of TIPS for hepatopulmonary syndrome.","volume":"113","author":"Corley","year":"1997","journal-title":"Gastroenterology"},{"key":"R83-2-20250326","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hep.1840210117","article-title":"Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy.","volume":"21","author":"Poterucha","year":"1995","journal-title":"Hepatology"},{"key":"R84-2-20250326","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1164\/ajrccm.158.2.9711041","article-title":"Pulmonary arteriovenous malformations. A state of the art review.","volume":"158","author":"Gossage","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R85-2-20250326","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4065\/72.1.44","article-title":"Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review.","volume":"72","author":"Krowka","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"R86-2-20250326","first-page":"113","article-title":"Hepatopulmonary syndrome and liver transplantation.","volume":"6","author":"Krowka","year":"2000","journal-title":"Liver Transpl"},{"key":"R87-2-20250326","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group.","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"R88-2-20250326","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007890-199702270-00020","article-title":"Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension.","volume":"63","author":"Kuo","year":"1997","journal-title":"Transplantation"},{"key":"R89-2-20250326","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.510300307","article-title":"Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension.","volume":"30","author":"Krowka","year":"1999","journal-title":"Hepatology"},{"key":"R90-2-20250326","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/archinte.1991.00400120029005","article-title":"Hepatic hydrothorax. Cause and management.","volume":"151","author":"Alberts","year":"1991","journal-title":"Arch Intern Med"},{"key":"R91-2-20250326","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.510250611","article-title":"The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt.","volume":"25","author":"Gordon","year":"1997","journal-title":"Hepatology"},{"key":"R92-2-20250326","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1111\/j.1572-0241.2002.07126.x","article-title":"Videoassisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax.","volume":"97","author":"Ferrante","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R93-2-20250326","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJM197406062902326","article-title":"Timing of cholestyramine doses in cholestatic liver disease. Letter.","volume":"290","author":"Javitt","year":"1974","journal-title":"N Engl J Med"},{"key":"R94-2-20250326","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","article-title":"Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a doubleblind, crossover, randomized trial.","volume":"94","author":"Ghent","year":"1988","journal-title":"Gastroenterology"},{"key":"R95-2-20250326","first-page":"1404","article-title":"Management of the pruritus of cholestasis: potential role of opiate antagonists.","volume":"86","author":"Bergasa","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"R96-2-20250326","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","article-title":"Oral naltrexone treatment for cholestatic pruritus: a doubleblind, placebocontrolled study.","volume":"113","author":"Wolfhagen","year":"1997","journal-title":"Gastroenterology"},{"key":"R97-2-20250326","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.510280315","article-title":"Bone mineral density, serum insulinlike growth factor I, and bone turnover markers in viral cirrhosis.","volume":"28","author":"GallegoRojo","year":"1998","journal-title":"Hepatology"},{"key":"R98-2-20250326","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1440-1746.1996.tb00284.x","article-title":"Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis?","volume":"11","author":"Chen","year":"1996","journal-title":"J Gastroenterol Hepatol"},{"key":"R99-2-20250326","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/0016-5085(90)90635-E","article-title":"Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids.","volume":"99","author":"Van Berkum","year":"1990","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"R100-2-20250326","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.50.suppl_1.i1","article-title":"Guidelines on the management of osteoporosis associated with chronic liver disease.","volume":"50","author":"Collier","year":"2002","journal-title":"Gut"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.20379","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200503000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T14:58:51Z","timestamp":1743260331000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200503000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.20379","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}